Target Name: CYP4F29P
NCBI ID: G54055
Other Name(s): CYP4F-se4[6:7:8] | C21orf15 | CYP4F3LP | cytochrome P450 family 4 subfamily F member 29, pseudogene | 4F-se4[6:7:8] | Cytochrome P450 family 4 subfamily F member 29, pseudogene

CYP4F29P: A Drug Target / Disease Biomarker

CYP4F29P is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the CYP4F family of proteins, which are known for their role in drug metabolism and transport. CYP4F29P is unique among its family members because of its ability to interact with a wide range of drugs, making it a promising drug target for researchers.

One of the key reasons why CYP4F29P is a promising drug target is its high degree of interdependence with other proteins. CYP4F29P is able to interact with a wide range of drugs, including many statins, which are used to treat heart disease. By binding to CYP4F29P, these drugs are able to influence the metabolism of the drugs, which can lead to reduced levels of the drugs in the body.

Another reason why CYP4F29P is a promising drug target is its role in the detoxification of drugs. Many drugs are designed to be eliminated from the body by the liver, and CYP4F29P is involved in this process. By interacting with the enzyme CYP3A4, which is responsible for metabolizing many drugs, CYP4F29P helps to regulate the amount of these drugs in the body.

In addition to its role in drug metabolism and detoxification, CYP4F29P is also involved in the regulation of cellular signaling pathways. It is a member of the TOR signaling pathway, which is a critical pathway that regulates cell growth, metabolism, and survival. This pathway is involved in the development and maintenance of many tissues in the body, including the brain and heart.

CYP4F29P is also involved in the regulation of inflammation. Many drugs are used to treat inflammatory conditions, and CYP4F29P is involved in the regulation of the immune response. By interacting with the protein NF-kappa-B, which is a key regulator of inflammation, CYP4F29P helps to regulate the amount of inflammatory mediators in the body.

Despite its many functions, CYP4F29P is not yet well understood. There are many researchers who are studying its role in drug metabolism, detoxification, and signaling pathways, but much more work is needed to fully understand its mechanisms of action. As more research is done, however, it is likely that CYP4F29P will be found to be a valuable drug target for researchers who are working to develop new treatments for a wide range of diseases.

Protein Name: Cytochrome P450 Family 4 Subfamily F Member 29, Pseudogene

More Common Targets

CYP4F3 | CYP4F30P | CYP4F34P | CYP4F35P | CYP4F59P | CYP4F62P | CYP4F8 | CYP4V2 | CYP4X1 | CYP4Z1 | CYP4Z2P | CYP51A1 | CYP51A1-AS1 | CYP51A1P1 | CYP51A1P2 | CYP51A1P3 | CYP7A1 | CYP7B1 | CYP8B1 | CYREN | CYRIA | CYRIB | CYS1 | CYSLTR1 | CYSLTR2 | CYSRT1 | Cysteine Protease | CYSTM1 | CYTB | CYTH1 | CYTH2 | CYTH3 | CYTH4 | CYTIP | CYTL1 | Cytochrome b5 reductase | Cytochrome bc1 complex | Cytochrome c oxidase | Cytochrome P450 1A (CYP1A) | Cytochrome P450 26 | Cytochrome P450 3A (CYP3A) | Cytochrome P450 4A | Cytochrome P450 Enzymes | Cytohesin | Cytoplasmatic dynein | Cytoplasmic dynein complex | CYTOR | CYYR1 | CYYR1-AS1 | CZIB | D21S2088E | D2HGDH | DAAM1 | DAAM2 | DAAM2-AS1 | DAB1 | DAB1-AS1 | DAB2 | DAB2IP | DACH1 | DACH2 | DACT1 | DACT2 | DACT3 | DACT3-AS1 | DAD1 | DAG1 | DAGLA | DAGLB | DALRD3 | DANCR | DAND5 | DANT2 | DAO | DAOA | DAOA-AS1 | DAP | DAP3 | DAPK1 | DAPK1-IT1 | DAPK2 | DAPK3 | DAPL1 | DAPP1 | DARS1 | DARS1-AS1 | DARS2 | DAW1 | DAXX | DAZ1 | DAZ2 | DAZ3 | DAZ4 | DAZAP1 | DAZAP2 | DAZAP2P1 | DAZL | DBET | DBF4 | DBF4B